Abiraterone boosts survival for castration-resistant CATumour remains dependent on androgen receptor signalling for growth Target testing for those at highest risk has valueHigher the initial PSA, the greater the risk of aggressive prostate cancer Dutasteride may slow early prostate CA growth A viable alternative for men with low-risk prostate cancer Intermittent ADT as effective as continuous Intermittent androgen deprivation therapy (ADT) may be just as effective as continuous ADT in men with PSA recurrence after radical therapy for prostate cancer, according to a new Canadian study. Capecitabine cuts risk of skin cancer in organ transplant recipients Triple Negative Breast Cancer Sensitive to Chemo Lower 10-year survival than other forms of breast CA Yoga lessens arm disability after breast cancer treatment Women reported significant positive changes to wellbeing after pilot program Nonmelanoma skin cancers on rise in U.S. The incidence of nonmelanoma skin cancers—mainly basal cell and squamous cell carcinomas—continues to rise in the U.S., researchers reported here. Private clinics to offer mammography with lowest possible dose Trillium Radiology Associates in Toronto first in North America to offer women mammography with the lowest possible dose. Weightlifting lowers lymphedema risk in breast cancer patients Study findings throw doubt on recommendations against upper body exercise First Previous 59 60 61 62 63 Next Last
